ArticleBMJ open2025

Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial.

Patrick J McNamara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.